Transaction · 0001055726-25-000004

Sumner Michael John

Sumner Michael John, CMO, reported a transaction classified as grant at INOVIO PHARMACEUTICALS, INC. involving 34650.000000 shares for an estimated $0.00. Reported holdings after the transaction were 34650.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO
INOINOVIO PHARMACEUTICALS, INC.
Filing timeFeb 28
Trade dateFeb 27, 2025
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

INO price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
INO since 2025-02-28Filed 576 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001055726-25-000004
Restricted Stock Unit
Transaction date
Feb 27, 2025
Filed Feb 28, 2025, 11:05 PM · 1d delay
Shares
34.6k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
34.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5…

  2. F2

    The vesting schedule for the 42,900 options is as follows: 21,450 shares vested on February 27, 2025 and 21,450 shares will vest on February 26, 2026.

  3. F3

    Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 is as follows: 1…

Original filing · 0001055726-25-000004
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

INO